Novus Therapeutics, Inc. (NVUS) has 13 open-market insider trades by 9 insiders since 2017. The most active filer is Catherine C. Turkel, President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Erez Chimovits | Dir | — | 1 | $4.0M | 2020-01-14 |
| Logos Global Management LP | 10% Owner | — | 1 | $3.6M | 2020-10-30 |
| OrbiMed Israel GP Ltd. via Erez Chimovits | 10% Owner | — | 1 | $2.2M | 2020-12-02 |
| OrbiMed Israel BioFund GP Limited Partnership via Erez Chimovits | Dir10% Owner | — | 1 | $2.0M | 2020-01-14 |
| Gregory J. Flesher | CEO | — | 2 | $1.2M | 2019-05-21 |
| Catherine C. Turkel | Pres | — | 4 | $566K | 2019-05-21 |
| Christine Ocampo | — | — | 1 | $200K | 2017-05-10 |
| Jon Kuwahara | — | — | 1 | $10K | 2019-05-21 |
| Paul Yook | 10% | — | 1 | $540 | 2019-04-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| OrbiMed Israel GP Ltd. | 10% Owner | Sell | $2.2M | 2020-12-02 |
| Logos Global Management LP | 10% Owner | Buy | $2.9M | 2020-10-30 |
| Logos Global Management LP | 10% Owner | Sell | $690K | 2020-10-30 |
| Jon Kuwahara | — | Sell | $10K | 2019-05-20 |
| Gregory J. Flesher | CEO | Sell | $29K | 2019-05-20 |
| Catherine C. Turkel | President | Sell | $19K |
Companies that share insiders with NVUS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-05-20 |
| OrbiMed Israel BioFund GP Limited Partnership | Director & 10% | Buy | $2.0M | 2019-05-02 |
| Erez Chimovits | Director | Buy | $4.0M | 2019-05-02 |
| Paul Yook | 10% | Sell | $540 | 2019-04-30 |
| Catherine C. Turkel | President | Buy | $322K | 2018-09-11 |
| Catherine C. Turkel | President | Buy | $3K | 2018-09-05 |
| Christine Ocampo | — | Buy | $200K | 2017-05-10 |
| Catherine C. Turkel | — | Buy | $222K | 2017-05-10 |
| Gregory J. Flesher | CEO | Buy | $1.2M | 2017-05-10 |